WT1 and carcinoma: In addition to WT1, we also found carcinoma-specific upregulation of LGALS3 (galectin-3) and UCHL1 (PGP9.5) (also upregulated in adenoma), which has been suggested as an IHC marker in parathyroid carcinoma72,73.